Lakeland, FL, March 12, 2026 (GLOBE NEWSWIRE)-- This article contains affiliate links. If a purchase is made through these links, a commission may be earned at no additional cost to the buyer. This ...
LOS ANGELES, CA / ACCESS Newswire / March 12, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals ...
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced new open-label extension study data for repinatrabit (JNT-517), demonstrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results